Bioventus Inc. (BVS) Tops Q1 EPS by 4c

Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $123.9 million versus the consensus estimate of $122.7 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c